Pancreatic Cancer Trial, Recruiting NCT06541340 Sponsor: Ruijin Hospital Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT06541340
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with pancreatic head cancer (either confirmed by tissue biopsy or agreed upon by a specialist medical team), who have yellowing of the skin caused by the tumour blocking the bile duct, and who are planned to have a major surgery to remove the affected part of the pancreas
  • People whose scans show the tumour can be fully removed by surgery
  • People whose blood bilirubin level (a substance that causes jaundice) is at or above 250μmol/L before treatment, and who have not yet had any procedure to drain the bile duct
  • People aged between 19 and 75 years old
  • People who have a general health and activity level that falls within an acceptable range as assessed by a standard medical scoring system (confirm with trial site)
  • People who have given written consent to participate, and whose suitability for a bile duct drainage procedure and surgery timing has been assessed

Who may not be able to join:

  • People who also have another type of cancer
  • People who have other serious or uncontrolled health conditions or organ problems that would make surgery unsafe
  • People who are pregnant or breastfeeding
  • People who are unable to safely undergo the bile duct drainage procedure or the planned surgery
  • People whose situation is considered unsuitable for other reasons not listed above (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 18917530547

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 August 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

In-hospital complications

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov